Skip to main content
. Author manuscript; available in PMC: 2019 Jun 3.
Published in final edited form as: Exp Cell Res. 2017 Oct 7;361(1):101–111. doi: 10.1016/j.yexcr.2017.10.007

Fig. 8. LEG EECD34, but not EOM EECD34, derived myotubes are longer following retinoic acid treatment.

Fig. 8.

EOM and LEG EECD34 mean myotube lengths after treatment with vehicle (control), retinoic acid (RA), BMS493 (RARinhib), or UVI 3003 (RXRinhib). * indicates significant difference from EOM-derived or LEG-derived EECD34 cells treated with vehicle. # indicates significant difference from retinoic acid (RA) treatment. n = number of replicates. Data are statistically significant at p ≤ 0.05.